english
stringlengths 2
1.37k
|
|---|
Medicinal product subject to medical prescription.
|
- if the seal is broken.
|
10
|
sexual dysfunction
|
For additional instructions for use and handling and disposal see section 6.6.
|
Store in a refrigerator (2°C – 8°C)
|
In patients scheduled for major elective orthopaedic surgery the cause of anaemia should be established and treated, if possible, before the start of epoetin alfa treatment.
|
BATCH NUMBER
|
Absorption The absorption of orally ingested melatonin is complete in adults and may be decreased by up to 50% in the elderly.
|
What Aprovel is and what it is used for 2.
|
Note If required, CellCept 1 g/ 5 ml powder for oral suspension can be administered via a nasogastric tube with a minimum size of 8 French (minimum 1.7 mm interior diameter).
|
If you drive or use tools or machines: watch out for signs of a hypo.
|
OUTER CARTON
|
PHARMACEUTICAL FORM
|
d Carton of the presentations of 28, 98 and 500 film-coated tablets in HDPE bottles / HDPE bottle
|
PHARMACEUTICAL FORM AND CONTENTS
|
Arixtra 7.5 mg/ 0.6 ml injection fondaparinux Na
|
The advisability of driving should be considered in these circumstances.
|
Efficacy of Azomyr syrup has not been investigated in paediatric trials in children less than 12 years of age.
|
Your doctor may test if you have an allergic reaction to imiglucerase.
|
anuria, haemolytic uraemic syndrome nephropathy, cystitis haemorrhagic
|
Breast pain
|
Injection site pain
|
Medicinal product subject to medical prescription.
|
Drugs used in erectile dysfunction, ATC Code:
|
3.
|
Active substance:
|
2.
|
The Committee for Medicinal Products for Human Use (CHMP) concluded that the effectiveness of adding rosiglitazone to sulphonylureas, especially glimepiride, had been shown sufficiently.
|
3.
|
Succursale belge/ Belgisch bijhuis Tél/ Tel: +32 (0) 800 38693 MSDBelgium_info@merck. com
|
Use the product immediately once the powder is completely dissolved.
|
Malta Joseph Cassar Ltd.
|
Population pharmacokinetic analysis including 96 paediatric patients aged 10 to 18 years and weighing 35 to 178 kg suggested similar mean CL/ F in children and adults.
|
- danazol (medicine acting on ovulation),
|
Amgen Europe B. V.
|
CONDITIONS OF THE MARKETING AUTHORISATION
|
Common:
|
13.
|
Advagraf belongs to a group of medicines called immunosuppressants.
|
The primary efficacy variable of the trial was overall survival.
|
1 pre-filled syringe
|
SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
|
111 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
|
Marketing Authorisation Holder and Manufacturer
|
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
|
41 2.
|
If after a dose reduction, haemoglobin continues to increase, the dose should be temporarily withheld until the haemoglobin begins to decrease, at which point therapy should be reinitiated at approximately 25% lower than the previous dose.
|
Protect from excessive heat and sunlight.
|
ANNEX I
|
Also, the long-term safety effects concerning growth, maturation, and cognitive and behavioural development of ARICLAIM in this age group have not yet been demonstrated.
|
7.
|
You may need to read it again. • If you have further questions, please ask your doctor or your pharmacist. • This medicine has been prescribed for you or your child.
|
If convenient, the gluteal region or the deltoid region may also be used.
|
13.
|
Powder and solvent for solution for injection.
|
STATEMENT OF ACTIVE SUBSTANCE(S)
|
OTHER SPECIAL WARNING(S), IF NECESSARY
|
Common:
|
6.
|
Each coated tablet contains 127 mg lactose monohydrate.
|
The results of flow cytometric analysis of CD34+ cell numbers vary depending on the precise methodology used and therefore, recommendations of numbers based on studies in other laboratories need to be interpreted with caution.
|
> 1st-line therapy
|
You may have a very rare serious allergic reaction to Actraphane or one of its ingredients (called a systemic allergic reaction).
|
3.
|
6.1 List of excipients
|
Caution should be used and close monitoring considered when administering Interferon beta to patients with severe renal failure.
|
2.
|
EU/ 1/ 04/ 285/ 020 10 pens of 3 ml.
|
Do not freeze.
|
Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use
|
43 10.
|
13.
|
4.5 Interaction with other medicinal products and other forms of interaction
|
Metabolism and nutrition disorders hypercholesterolaemia1 hypertriglyceridaemia
|
10.
|
Irbesartan does not require metabolic activation for its activity.
|
Adult cancer patients with symptomatic anaemia receiving chemotherapy
|
The product dissolves rapidly (usually in less than 1 minute).
|
Arava 10 mg film-coated tablets Leflunomide
|
1 pre-filled syringe
|
Detailed information on this medicine is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/
|
Results of an epidemiological study found that there was no increased risk of suicidality with aripiprazole compared to other antipsychotics among patients with bipolar disorder.
|
In a 144-week open-label randomised clinical study (GS-01-934) antiretroviral treatment-naïve HIV-1 infected patients received either a once-daily regimen of efavirenz, emtricitabine and tenofovir disoproxil fumarate or a fixed combination of lamivudine and zidovudine (Combivir) administered twice daily and efavirenz once daily (please refer to the Summary of Product Characteristics for Truvada).
|
INFORMATION IN BRAILLE
|
Repeat every 24 hours.
|
3.
|
Betaferon therapy should not be started if you are pregnant (see also ‘Do not use Betaferon’).
|
Aripiprazole is extensively metabolised by the liver primarily by three biotransformation pathways: dehydrogenation, hydroxylation, and N-dealkylation.
|
- patients with New York Heart Association Class 2 or greater heart failure in the last 6 months,
|
Aerius 5 mg orodispersible tablet is indicated for adults and adolescents (12 years of age and older).
|
Imiquimod has the potential to exacerbate inflammatory conditions of the skin.
|
This suggests that pemetrexed may impair male fertility.
|
Uncommon: nasopharyngitis, pharyngitis, sinusitis
|
10.
|
PHARMACEUTICAL FORM AND CONTENTS
|
For Aranesp no clinical data on exposed pregnancies are available.
|
EU/ 1/ 02/ 206/ 022
|
If the rise in haemoglobin is greater than 2 g/ dl (1.25 mmol/ l) in four weeks reduce the dose by approximately 25%, depending on the rate of increase.
|
In the overdose cases below 140 mg or unknown dose the patients revealed symptoms from central nervous system (confusion, drowsiness, somnolence, vertigo, agitation, aggression, hallucination, and gait disturbance) and/ or gastrointestinal origin (vomiting and diarrhoea).
|
End of preview. Expand
in Dataset Viewer.
- Downloads last month
- 0